Cross-Protection against MERS-CoV by Prime-Boost Vaccination Using Viral Spike DNA and Protein
- PMID: 32967955
- PMCID: PMC7925194
- DOI: 10.1128/JVI.01176-20
Cross-Protection against MERS-CoV by Prime-Boost Vaccination Using Viral Spike DNA and Protein
Abstract
Middle East respiratory syndrome coronavirus (MERS-CoV) causes severe respiratory illness and has a high mortality of ∼34%. However, since its discovery in 2012, an effective vaccine has not been developed for it. To develop a vaccine against multiple strains of MERS-CoV, we targeted spike glycoprotein (S) using prime-boost vaccination with DNA and insect cell-expressed recombinant proteins for the receptor-binding domain (RBD), S1, S2, SΔTM, or SΔER. Our S subunits were generated using an S sequence derived from the MERS-CoV EMC/2012 strain. We examined humoral and cellular immune responses of various combinations with DNA plasmids and recombinant proteins in mice. Mouse sera immunized with SΔER DNA priming/SΔTM protein boosting showed cross-neutralization against 15 variants of S-pseudovirions and the wild-type KOR/KNIH/002 strain. In addition, these immunizations provided full protection against the KOR/KNIH/002 strain challenge in human DPP4 knock-in mice. These findings suggest that vaccination with the S subunits derived from one viral strain can provide cross-protection against variant MERS-CoV strains with mutations in S. DNA priming/protein boosting increased gamma interferon production, while protein-alone immunization did not. The RBD subunit alone was insufficient to induce neutralizing antibodies, suggesting the importance of structural conformation. In conclusion, heterologous DNA priming with protein boosting is an effective way to induce both neutralizing antibodies and cell-mediated immune responses for MERS-CoV vaccine development. This study suggests a strategy for selecting a suitable platform for developing vaccines against MERS-CoV or other emerging coronaviruses.IMPORTANCE Coronavirus is an RNA virus with a higher mutation rate than DNA viruses. Therefore, a mutation in S-protein, which mediates viral infection by binding to a human cellular receptor, is expected to cause difficulties in vaccine development. Given that DNA-protein vaccines promote stronger cell-mediated immune responses than protein-only vaccination, we immunized mice with various combinations of DNA priming and protein boosting using the S-subunit sequences of the MERS-CoV EMC/2012 strain. We demonstrated a cross-protective effect against wild-type KOR/KNIH/002, a strain with two mutations in the S amino acids, including one in its RBD. The vaccine also provided cross-neutralization against 15 different S-pseudotyped viruses. These suggested that a vaccine targeting one variant of S can provide cross-protection against multiple viral strains with mutations in S. The regimen of DNA priming/Protein boosting can be applied to the development of other coronavirus vaccines.
Keywords: MERS-CoV; vaccines.
Copyright © 2020 Choi et al.
Figures
![FIG 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/7925194/bin/JVI.01176-20-f0001.gif)
![FIG 2](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/7925194/bin/JVI.01176-20-f0002.gif)
![FIG 3](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/7925194/bin/JVI.01176-20-f0003.gif)
![FIG 4](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/7925194/bin/JVI.01176-20-f0004.gif)
![FIG 5](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/7925194/bin/JVI.01176-20-f0005.gif)
Similar articles
-
Characterization of novel monoclonal antibodies against MERS-coronavirus spike protein.Virus Res. 2020 Mar;278:197863. doi: 10.1016/j.virusres.2020.197863. Epub 2020 Jan 13. Virus Res. 2020. PMID: 31945421 Free PMC article.
-
Prospects for a MERS-CoV spike vaccine.Expert Rev Vaccines. 2018 Aug;17(8):677-686. doi: 10.1080/14760584.2018.1506702. Epub 2018 Aug 9. Expert Rev Vaccines. 2018. PMID: 30058403 Free PMC article. Review.
-
Heterologous prime-boost vaccination with adenoviral vector and protein nanoparticles induces both Th1 and Th2 responses against Middle East respiratory syndrome coronavirus.Vaccine. 2018 Jun 7;36(24):3468-3476. doi: 10.1016/j.vaccine.2018.04.082. Epub 2018 May 5. Vaccine. 2018. PMID: 29739720 Free PMC article.
-
Recombinant Receptor-Binding Domains of Multiple Middle East Respiratory Syndrome Coronaviruses (MERS-CoVs) Induce Cross-Neutralizing Antibodies against Divergent Human and Camel MERS-CoVs and Antibody Escape Mutants.J Virol. 2016 Dec 16;91(1):e01651-16. doi: 10.1128/JVI.01651-16. Print 2017 Jan 1. J Virol. 2016. PMID: 27795425 Free PMC article.
-
MERS-CoV spike protein: Targets for vaccines and therapeutics.Antiviral Res. 2016 Sep;133:165-77. doi: 10.1016/j.antiviral.2016.07.015. Epub 2016 Jul 26. Antiviral Res. 2016. PMID: 27468951 Free PMC article. Review.
Cited by
-
Nucleic acid vaccine candidates encapsulated with mesoporous silica nanoparticles against MERS-CoV.Hum Vaccin Immunother. 2024 Dec 31;20(1):2346390. doi: 10.1080/21645515.2024.2346390. Epub 2024 May 1. Hum Vaccin Immunother. 2024. PMID: 38691025 Free PMC article.
-
The mechanisms and factors that induce trained immunity in arthropods and mollusks.Front Immunol. 2023 Sep 7;14:1241934. doi: 10.3389/fimmu.2023.1241934. eCollection 2023. Front Immunol. 2023. PMID: 37744346 Free PMC article. Review.
-
Orf virus DNA prime-protein boost strategy is superior to adenovirus-based vaccination in mice and sheep.Front Immunol. 2023 Mar 21;14:1077938. doi: 10.3389/fimmu.2023.1077938. eCollection 2023. Front Immunol. 2023. PMID: 37026014 Free PMC article.
-
Evaluation of the Immune Response Afforded by Combined Immunization with Orf Virus DNA and Subunit Vaccine in Mice.Vaccines (Basel). 2022 Sep 8;10(9):1499. doi: 10.3390/vaccines10091499. Vaccines (Basel). 2022. PMID: 36146577 Free PMC article.
-
A Recombinant Subunit Vaccine Induces a Potent, Broadly Neutralizing, and Durable Antibody Response in Macaques against the SARS-CoV-2 P.1 (Gamma) Variant.ACS Infect Dis. 2022 Apr 8;8(4):825-840. doi: 10.1021/acsinfecdis.1c00600. Epub 2022 Mar 9. ACS Infect Dis. 2022. PMID: 35263081 Free PMC article.
References
-
- van Boheemen S, de Graaf M, Lauber C, Bestebroer TM, Raj VS, Zaki AM, Osterhaus AD, Haagmans BL, Gorbalenya AE, Snijder EJ, Fouchier RA. 2012. Genomic characterization of a newly discovered coronavirus associated with acute respiratory distress syndrome in humans. mBio 3:e00473-12. doi:10.1128/mBio.00473-12. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous